Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-02

Clinical Trial Update: Weaning Approaches for Vasopressin in Sepsis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating strategies to wean vasopressin in septic shock; status is recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VASOPRESSIN (VASOPRESSIN)

Snippet

Sponsor: Hospital Nossa Senhora da Conceicao | Conditions: Septic Shock | Phase 3 | Status: RECRUITING